Sarepta Therapeutics, Inc. — Director's Dealing 2017

Aug 7, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sarepta Therapeutics, Inc. (SRPT)
CIK: 0000873303
Period of Report: 2017-08-03

Reporting Person: Mahatme Sandesh (EVP, CFO & CBO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-08-03	Common Stock	M	13298	—	Acquired	47159	Direct
2017-08-03	Common Stock	F	6264	$37.88	Disposed	40895	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-08-03	Restricted Stock Units	$	M	13298	Disposed		Common Stock (13298)	Direct

Footnotes

F1: Restricted stock units convert into common stock on a one-for-one basis.

F2: Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of restricted stock units granted on March 3, 2017.

F3: On March 3, 2017, the reporting person was granted restricted stock units that vest based on the Company's satisfaction of certain performance criteria. The first performance criterion was met on August 3, 2017, resulting in vesting of 50% of such restricted stock units.